Stay updated on Fazirsiran in AATD Liver Disease Clinical Trial

Sign up to get notified when there's something new on the Fazirsiran in AATD Liver Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fazirsiran in AATD Liver Disease Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-01T06:26:40.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The web page has been updated to include new details about the study of fazirsiran (TAK-999, ARO-AAT), including specific dosing regimens, study periods, and various metrics for evaluating liver health. Additionally, the results reporting dates have been clarified.
    Difference
    100%
    Check dated 2025-04-24T01:27:11.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The page has undergone significant content removal, particularly regarding the study details for fazirsiran (TAK-999, ARO-AAT) related to Alpha-1 Antitrypsin Deficiency, including the study's purpose, participant criteria, and treatment procedures. The revision number has been updated from v2.14.4 to v2.15.0.
    Difference
    12%
    Check dated 2025-04-16T20:39:25.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-09T15:59:03.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-02T00:21:20.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    2%
    Check dated 2025-02-24T23:11:43.000Z thumbnail image

Stay in the know with updates to Fazirsiran in AATD Liver Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fazirsiran in AATD Liver Disease Clinical Trial page.